The animal selected for our study had long lasting multiple nodules without showing any signs of regression and treatment with autogenous vaccine
showed 97.5 percent efficiency in resolving the warts.
The size and shape of warts before and after administration of autogenous vaccine
prepared from bovine wart lesions in sterile glycerine solution were compared and clinical alterations were ascertained based on diminution in size, gradual desiccation, separation from under lying dermal base or regression and complete clinical cure based on full regression or complete shedding of warts or complete recovery.
In the present study, rapid regression of warts in group 2 animals suggested that auto-hemotherapy is helpful by augmenting the effects of autogenous vaccine
. Auto-hemotherapy for treatment of chronic diseases in human beings is an age old practice, but has gained limited public acceptability (Wallis, 1947; Olwin et al., 1997).
preparing and treatment of animals
was administered @ 5 ml, subcutaneously and was revaccinated at 7 day intervals for four weeks.
Age of animals Measures of control and prevention Piglets Autogenous vaccines
, oral vaccine, oral immunization with immunoglobulin (IgY), plasma protein powder, prophylactic antibiotics, or selection of animals that lack genes encoding the fimbrial receptors Gilts Adequate temperature control, active and passive immunization, or vaccination with bacterins or recombinant protein (2 doses) four and two weeks before delivery Sows Adequate temperature control, active and passive immunization, vaccination with bacterins or recombinant protein (1 dose) two weeks before delivery Table 3--Vaccination programs according to each manufacturer.
The use of autogenous vaccines
and virucidal teat dips may be recommended in herd outbreaks."
Emergency autogenous vaccines
can be manufactured by licensed laboratories.
In avian pasteurellosis, observation of multiple genotypes within an outbreak may hamper an autogenous vaccines
because one genotype could not cross-protected other.
3 April 2012 - French Sanofia[euro](tm)s (EPA:SAN) animal health arm Merial said it had purchased US autogenous vaccines
specialist Newport Laboratories for an undisclosed price.